Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: A meta-Analysis

Epidemiology and Infection

Volumn 142, Issue 6, 2014, Pages 1119-1137

  Hardefeldt, H A ^a   Cox, M R ^a   Eslick, G D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Human papilloma virus (HPV)

Indexed keywords

AFRICA; CANCER RISK; CARCINOGENESIS; CHINA; DEVELOPING COUNTRY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; NORTH AMERICA; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POPULATION RISK; PREVALENCE; REVIEW; SOUTHERN BLOTTING; VIRUS DETECTION;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS;

EID: 84898619535     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814000016     Document Type: Review

References (149)

1. Ferlay J, et al. GLOBOCAN 2008 v. 1.2 International Agency for Research on Cancer (http://globocan.iarc. fr). Accessed 6 January 2012.
2. US DHHS. A snapshot of esophageal cancer. US Department of Health and Human Services, National Institutes of Health, 2011.
3. Fast Stats. (http://seer.cancer.gov/faststats/index.php). Accessed 6 January 2012.
4. Morgan RJ, et al. Investigation of oesophageal adeno-carcinoma for viral genomic sequences. European Journal of Surgical Oncology 1997; 23: 24-29.
5. Holmes RS, Vaughan TL. Epidemiology and patho-genesis of esophageal cancer. Seminars in Radiation Oncology 2007; 17: 2-9.
6. Syrjänen KJ. HPV infections and oesophageal cancer. Journal of Clinical Pathology 2002; 55: 721-728.
7. Kamangar F, et al. Esophageal cancer in Northeastern Iran: a review. Archives of Iranian Medicine 2007; 10: 70-82.
8. zur Hausen H. Papillomaviruses in the causation of human cancers-A brief historical account. Virology 2009; 384: 260-265.
9. Smith JS, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-Analysis update. International Journal of Cancer 2007; 121: 621-632.
10. Syrjänen KJ. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Archiv fur Geschwulstforschung 1982; 52: 283-292.
11. Moher D, et al. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. Annals of Internal Medicine 2009; 151: 264-269, W264.
12. Emadian O, et al. Correlation of human papilloma-virus infection with esophageal squamous cell carcinoma. Journal of Babol University of Medical Sciences 2011; 13.
13. Erol D, et al. Investigation of the presence of human papillomavirus DNA in various gastrointestinal carcinoma samples. Mikrobiyoloji bülteni 2009; 43: 259-268.
14. Junquera F, et al. High prevalence of human papillo-mavirus in a spanish population with esophageal cancer. Gastroenterology 2009; 136: A459.
15. Kim WH, et al. Detection of human papillomavirus DNA in esophageal cancer using polymerase chain reaction. Korean Journal of Gastroenterology 1992; 24: 207-215.
16. DerSimonian R, Laird N. Meta-Analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-188.
17. Higgins JP, et al. Measuring inconsistency in meta-Analyses. British Medical Journal 2003; 327: 557-560.
18. Egger M, et al. Bias in meta-Analysis detected by a simple, graphical test. British Medical Journal 1997; 315: 629-634.
19. Orwin RG. A fail-safe N for effect size in meta-Analysis. Journal of Educational Statistics 1983; 8: 157-159.
20. Moradi A, et al. Detection of human papillomavirus DNA by PCR in esophageal squamous cell carcinoma from Turkmen Sahra, North-East of Iran. Iranian Biomedical Journal 2002; 6: 19-23.
21. Moradi A, Mokhtari-Azad T. Detection of HPV in cancerous and non-cancerous esophageal tissues from Turkmen-Sahra, Iran. International Journal of Cancer Research 2006; 2: 113-118.
22. Antonsson A, et al. High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer, Epidemiology, Biomarkers and Prevention 2010; 19: 2080-2087.
23. Astori G, et al. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 2001; 64: 9-14.
24. Bahnassy AA, et al. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival. Pathology International 2005; 55: 53-62.
25. Benamouzig R, et al. Absence of human papilloma-virus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroen-terology 1995; 109: 1876-1881.
26. Benamouzig R, et al. Human papillomavirus infection in esophageal squamous-cell carcinoma in western countries. International Journal of Cancer 1992; 50: 549-552.
27. Bjorge T, et al. A prospective, seroepidemiological study of the role of human papillomavirus in esopha-geal cancer in Norway. Cancer Research 1997; 57: 3989-3992.
28. Brandsma JL, Abramson AL. Association of papillo-mavirus with cancers of the head and neck. Otolaryng-ology-Head & Neck Surgery 1989; 115: 621-625.
29. Cao B, et al. LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 2005; 26: 1280-1284.
30. Chang F, et al. Detection of human papillomavirus DNA in cytologic specimens derived from esophageal precancer lesions and cancer. Scandinavian Journal of Gastroenterology 1990; 25: 383-388.
31. Chang F, et al. p53 overexpression and human papillo-mavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. Anticancer Research 1997; 17: 709-715.
32. Damin APS, et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the esophagus by auto-nested PCR. Diseases of the Esophagus 2006; 19: 64-68.
33. Dillner J, et al. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. British Medical Journal 1995; 311: 1346.
34. Farhadi M, et al. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World Journal of Gastroenterology 2005; 11: 1200-1203.
35. Fidalgo PO, et al. High prevalence of human papillo-mavirus in squamous cell carcinoma and matched normal esophageal mucosa: assessment by polymerase chain reaction. Cancer 1995; 76: 1522-1528.
36. Gao G-F, et al. No association between HPV infection and the neoplastic progression of esophageal squa-mous cell carcinoma: result from a cross-sectional study in a high-risk region of China. International Journal of Cancer 2006; 119: 1354-1359.
37. Han C, et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. Journal of the National Cancer Institute 1996; 88: 1467-1471.
38. He D, et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. International Journal of Cancer 1997; 72: 959-964.
39. Hussain S, et al. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. Journal of Receptors and Signal Trans-duction 2011; 31: 147-156.
40. Kamangar F, et al. Human papillomavirus serol-ogy and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. International Journal of Cancer 2006; 119: 579-584.
41. Katiyar S, et al. p53 gene mutation and human papil-lomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Letters 2005; 218: 69-79.
42. Kawaguchi H, et al. p53 polymorphism in human papillomavirus-Associated esophageal cancer. Cancer Research 2000; 60: 2753-2755.
43. Khurshid A, et al. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. Journal of the Pakistani Medical Association 1998; 48: 138-142.
44. Kiki I, et al. Detection of human papillomavirus infection in esophageal carcinomas by the histopathological method and polymerase chain reaction technique. Turkish Journal of Medical Sciences 2002; 32: 223-230.
45. Koh JS, et al. No association of high-risk human papillomavirus with esophageal squamous cell carcinomas among Koreans, as determined by polymerase chain reaction. Diseases of the Esophagus 2008; 21: 114-117.
46. Kulski J, et al. Human papilloma virus DNA in oeso-phageal carcinoma. Lancet 1986; 2: 683-684.
47. Lagergren J, et al. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiolo-gic case-control study in Sweden. Journal of the National Cancer Institute 1999; 91: 156-162.
48. Lambot MA, et al. Evaluation of the role of human papillomavirus in oesophageal squamous cell carcinoma in Belgium. Acta Gastroenterologica Belgica 2000; 63: 154-156.
49. Lenhart D, et al. Association of human papillomavirus with esophageal neoplasms. Diseases of the Esophagus 1991; 4: 123-128.
50. Li T, et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcino-genesis 2001; 22: 929-934.
51. Li T, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-Associated carcinomas in China. Cancer 2002; 95: 2571-2576.
52. Liu WK, et al. The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squa-mous cell carcinoma. Virology 2005; 150: 991-1001.
53. Liu WK, et al. The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. European Journal of Gastroenterology and Hepatology 2010; 22: 67-74.
54. Loke SL, et al. Human papillomavirus in oesophageal squamous cell carcinoma. Journal of Clinical Pathology 1990; 43: 909-912.
55. Lu XM, et al. Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. European Journal of Surgical Oncology 2008; 34: 765-770.
56. Lu X-M, et al. p53 polymorphism in human papillomavirus-Associated Kazakh's esophageal cancer in Xinjiang, China. World Journal of Gastroenterology 2004; 10: 2775-2778.
57. Lyronis ID, et al. K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with eso-phageal squamous carcinoma. Pathology and Oncology Research 2008; 14: 267-273.
58. Lyronis ID, et al. Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. International Journal of Biological Markers 2005; 20: 5-10.
59. Matsha T, et al. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 2007; 369: 182-190.
60. Mir MM, et al. The Association of beta-catenin gene mutations and human papillomavirus in carcinoma of esophagus in a high-risk population of India. International Journal of Health Sciences 2007; 1: 177-183.
61. Mizobuchi S, et al. Absence of human papillo-mavirus-16 and-18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Japanese Journal of Clinical Oncology 1997; 27: 1-5.
62. Mori M, et al. Papillomavirus and esophageal cancer in the Japanese and Chinese. American Journal of Gastroenterology 1989; 84: 1126-1127.
63. Pantelis A, et al. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squa-mous cell carcinoma patient cohort. Oncology Reports 2007; 17: 1243-1248.
64. Peixoto Guimaraes D, et al. Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Letters 2001; 162: 231-235.
65. Qi ZL, et al. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Experimental Oncology 2006; 28: 235-240.
66. Rugge M, et al. p53 alterations but no human papillo-mavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer, Epidemiology, Biomarkers and Prevention 1997; 6: 171-176.
67. Shen Z-Y, et al. Detection of human papillomavirus in esophageal carcinoma. Journal of Medical Virology 2002; 68: 412-416.
68. Togawa K, et al. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gas-troenterology 1994; 107: 128-136.
69. Van Doornum GJ, et al. Reactivity to human papillo-mavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. British Journal of Cancer 2003; 88: 1095-1100.
70. van Rensburg EJ, Venter EH, Simson IW. Human papillomavirus DNA in aerodigestive squamous carcinomas demonstrated by means of in situ hybridisation. South African Medical Journal 1993; 83: 516-518.
71. Weston AC, Prolla JC. Association between esopha-geal squamous cell carcinoma and human papilloma-virus detected by Hybrid Capture II assay. Diseases of the Esophagus 2003; 16: 224-228.
72. Williamson AL, Jaskiesicz K, Gunning A. The detection of human papillomavirus in oesophageal lesions. Anticancer Research 1991; 11: 263-265.
73. Yang WJ, et al. P53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Molecular Carcinogenesis 2008; 47: 100-104.
74. Yao P-F, et al. Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World Journal of Gastroenterology 2006; 12: 1352-1355.
75. Zhang D, et al. Comparison of prevalence, viral load, physical status and expression of human papillo-mavirus-16,-18 and-58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010; 10: 650.
76. Zhang D-H, et al. Prevalence and association of human papillomavirus 16, Epstein-Barr virus, herpes simplex virus-1 and cytomegalovirus infection with human esophageal carcinoma: a case-control study. Oncology Reports 2011; 25: 1731-1738.
77. Zhang Q-Y, et al. Infection and integration of human papillomavirus in esophageal carcinoma. International Journal of Hygiene & Environmental Health 2011; 214: 156-161.
78. Zhou X-B, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World Journal of Gastro-enterology 2003; 9: 1170-1173.
79. Abdirad A, et al. Human papillomavirus detected in esophageal squamous cell carcinoma in Iran. European Journal of Internal Medicine 2011.
80. Acevedo-Nuno E, et al. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Research 2004; 24: 1319-1323.
81. Akutsu N, et al. Rare association of human papilloma-virus DNA with esophageal cancer in Japan. Journal of Infectious Diseases 1995; 171: 425-428.
82. Awerkiew S, et al. Esophageal cancer in Germany is associated with Epstein-Barr virus but not with papil-lomaviruses. Medical Microbiology and Immunology 2003; 192: 137-140.
83. Ayshamgul H, et al. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Chinese Medical Journal (English) 2011; 124: 341-346.
84. Baines JE, et al. Consensus-degenerate hybrid oligonu-cleotide primers (CODEHOP) for the detection of novel papillomaviruses and their application to eso-phageal and tonsillar carcinomas. Journal of Virology Methods 2005; 123: 81-87.
85. Bognar G, et al. Possible role of human papilloma virus infection in response to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterol-ogy 2008; 55: 93-97.
86. Castillo A, et al. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World Journal of Gastroenterology 2006; 12: 6188-6192.
87. Chang F, et al. Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scandinavian Journal of Gastroenterology 2000; 35: 123-130.
88. Chang F, et al. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. International Journal of Cancer 1990; 45: 21-25.
89. Chang F, et al. Screening for human papillomavirus infections in esophageal squamous cell carcinomas by in situ hybridization. Cancer 1993; 72: 2525-2530.
90. Chang F, et al. Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scandinavian Journal of Gastroenter-ology 1992; 27: 553-563.
91. Chang FJ, et al. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Research 2000; 20: 3935-3940.
92. Chen B, Yin H, Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Human Pathology 1994; 25: 920-923.
93. de Villiers EM, et al. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences. International Journal of Cancer 2004; 109: 253-258.
94. de Villiers EM, et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. International Journal of Cancer 1999; 81: 225-228.
95. Ding GC, et al. Human papillomavirus DNA and P16 (INK4A) expression in concurrent esophageal and gastric cardia cancers. World Journal of Gastroenterology 2010; 16: 5901-5906.
96. Dreilich M, et al. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006; 6: 94.
97. Far AE, et al. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scandinavian Journal of Infectious Diseases 2007; 39: 58-62.
98. Furihata M, et al. The detection of either human papil-lomavirus genomes (types 16 and 18) or overexpressed p53 protein in esophageal cancers patients from Kochi, Japan [14]. American Journal of Gastroenterology 1993; 88: 471-472.
99. Furihata M, et al. Prognostic significance of human papillomavirus genomes (type-16,-18) and aberrant expression of p53 protein in human esophageal cancer. International Journal of Cancer 1993; 54: 226-230.
100. Goto A, et al. Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases. Journal of Medical Virology 2011; 83: 1383-1390.
101. Hale MJ, Liptz TR, Paterson AC. Association between human papillomavirus and carcinoma of the oesophagus in South African blacks. A histochemical and immunohistochemical study. South African Medical Journal 1989; 76: 329-330.
102. Hasegawa M, et al. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squa-mous cell carcinoma with HPV infection. Pathology International 2002; 52: 442-450.
103. Herrera-Goepfert R, et al. Human papilloma virus and esophageal carcinoma in a Latin-American region. World Journal of Gastroenterology 2009; 15: 3142-3147.
104. Hille JJ, et al. Human papillomavirus infection related to oesophageal carcinoma in black South Africans. A preliminary study. South African Medical Journal 1986; 69: 417-420.
105. Hille JJ, et al. Human papillomavirus and carcinoma of the esophagus. New England Journal of Medicine 1985; 312: 1707.
106. Hippelainen M, et al. Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Research 1993; 13: 677-681.
107. Kamath, et al. Investigation of the association of esophageal carcinoma with human papillomaviruses. Diseases of the Esophagus 2000; 13: 122-124.
108. Kiyabu MT, et al. Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. American Journal of Surgical Pathology 1989; 13: 221-224.
109. Kok TC, et al. No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. European Journal of Cancer 1997; 33: 1865-1868.
110. Koshiol J, et al. No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of Cancer 2010; 127: 93-100.
111. Kulski JK, et al. Survey of histologic specimens of human cancer for human papillomavirus types 6/11/16/18 by filter in situ hybridization. American Journal of Clinical Pathology 1990; 94: 566-570.
112. Lam KY, et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Human Pathology 1997; 28: 657-663.
113. Lavergne D, de Villiers EM. Papillomavirus in esopha-geal papillomas and carcinomas. International Journal of Cancer 1999; 80: 681-684.
114. Lewensohn-Fuchs I, et al. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Research 1994; 14: 1281-1285.
115. Matsha T, et al. Human papillomavirus associated with oesophageal cancer. Journal of Clinical Pathology 2002; 55: 587-590.
116. Miller BA, et al. Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives. International Journal of Cancer 1997; 71: 218-222.
117. Mohseni Mehran SM. Detection of human papilloma virus in esophageal squamous cell carcinoma in Guilan province. Journal of Clinical and Diagnostic Research 2010; 4: 2373-2377.
118. Morgan RJ, et al. Human papillomavirus and oeso-phageal squamous cell carcinoma in the UK. European Journal of Surgical Oncology 1997; 23: 513-517.
119. Nakamura T, et al. Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma. Surgery Today 1995; 25: 591-597.
120. Ogura H, et al. Human papillomavirus DNA in squa-mous cell carcinomas of the respiratory and upper digestive tracts. Japanese Journal of Clinical Oncology 1993; 23: 221-225.
121. Ono H, et al. Interrelationship between the expression of h-ras p21, C-myc and p53 proteins, and the infection of high-risk human papillomaviruses in Japanese patients with esophageal squamous-cell carcinoma. Oncology Reports 1994; 1: 831-836.
122. Ostrow RS, et al. A survey of human cancers for human papillomavirus DNA by filter hybridization. Cancer 1987; 59: 429-434.
123. Paz IB, et al. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squa-mous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997; 79: 595-604.
124. Poljak M, Cerar A. Human papillomavirus type 16 DNA in oesophageal squamous cell carcinoma. Anticancer Research 1993; 13: 2113-2116.
125. Poljak M, Cerar A, Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Human Pathology 1998; 29: 266-271.
126. Rakoczy P, et al. Detection of human papillomavirus type 16 DNA in cervical swabs and formalin-fixed, paraffin-embedded squamous cell carcinomas of non-genital tissues using a synthetic oligodeoxynucleotide probe. Journal of Virological Methods 1989; 25: 325-336.
127. Saegusa M. Absence of human papillomavirus geno-mic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. Journal of Clinical Pathology-Molecular Pathology 1997; 50: 101-104.
128. Shibagaki I, et al. p53 mutation, murine double minute 2 amplification, and human papilloma-virus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. Clinical Cancer Research 1995; 1: 769-773.
129. Shimada Y, et al. Genetic alterations in patients with esophageal cancer with short-And long-term survival rates after curative esophagectomy. Annals of Surgery 1997; 226: 162-168.
130. Shuyama K, et al. Human papillomavirus in high-And low-risk areas of oesophageal squamous cell carcinoma in China. British Journal of Cancer 2007; 96: 1554-1559.
131. Si HX, et al. Human papillomavirus infection and loss of heterozygosity in esophageal squamous cell carcinoma. Cancer Letters 2004; 213: 231-239.
132. Si HX, et al. Viral load of HPV in esophageal squa-mous cell carcinoma. International Journal of Cancer 2003; 103: 496-500.
133. Smits HL, et al. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. Journal of Medical Virology 1995; 46: 213-215.
134. Sobti RC, et al. Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population. Molecular and Cellular Biochemistry 2001; 217: 51-56.
135. Strickler HD, et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. European Journal of Cancer Prevention 1998; 7: 305-313.
136. Suzuk L, et al. Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer 1996; 78: 704-710.
137. Takahashi A, et al. High-risk human papillomavirus infection and overexpression of p53 protein in squa-mous cell carcinoma of the esophagus from Japan. Diseases of the Esophagus 1998; 11: 162-167.
138. Talamini G, et al. Alcohol, smoking and papilloma-virus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. International Journal of Cancer 2000; 86: 874-878.
139. Toh Y, et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992; 70: 2234-2238.
140. Tornesello ML, et al. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. Journal of Clinical Virology 2009; 45: 28-33.
141. Turner JR, et al. Low prevalence of human papilloma-virus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Human Pathology 1997; 28: 174-178.
142. Wang X, et al. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010; 10: 19.
143. White RE, et al. Absence of human papillomavirus in esophageal carcinomas from southwestern Kenya. Diseases of the Esophagus 2005; 18: 28-30.
144. Woo YJ, Yoon HK. In situ hybridization study on human papillomavirus DNA expression in benign and malignant squamous lesions of the esophagus. Journal of Korean Medical Science 1996; 11: 467-473.
145. Zheng J, et al. Lack of human papillomavirus types 16 and 18 DNA in esophageal squamous carcinoma cell lines. Chinese Medical Journal (English) 1999; 112: 534-537.
146. Government A. List of Developing Countries as declared by the Minister for Foreign Affairs. AusAID, Canberra, 2012.
147. Li SY, et al. Meta analysis on etiological relationship between human papillomavirus and esophageal carcinoma [in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009; 23: 85-87.
148. Wiedorn KH, et al. Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyra-mide signal amplification for the detection of HPV. Histochemistry and Cell Biology 1999; 111: 89-95.
149. Sitas F, et al. InterSCOPE Study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. Journal of the National Cancer Institute 2012; 104: 147-158.